GLP-1 coverage by insurance type: 2026 guide

Checked against federal rules and published state Medicaid changes: October 2026

Short answer

Almost every kind of insurance covers GLP-1 medicines for type 2 diabetes. Coverage for weight management is where plans differ: employers choose whether to include it, marketplace plans rarely do, Medicare excludes weight loss alone but runs a bridge program through 2027, and Medicaid coverage depends on the state, with 13 states covering it in January 2026 after several dropped it.

Coverage at a glance

Plans cover by approved use: Ozempic, Mounjaro and Rybelsus for type 2 diabetes; Wegovy, Zepbound and Foundayo for weight management; Wegovy also for lowering heart attack and stroke risk, and Zepbound for obstructive sleep apnea.

Employer plan bought from an insurer
Type 2 diabetes: Usually covered, often with prior authorization or step therapy.
Weight management: Only if the employer adds it; many do not.
Heart and sleep apnea uses: Wegovy for heart risk and Zepbound for sleep apnea often covered with prior authorization.
Self-funded employer plan
Type 2 diabetes: Usually covered, with the plan’s own criteria.
Weight management: The employer decides; state insurance rules do not apply.
Heart and sleep apnea uses: Often covered with prior authorization.
Marketplace (ACA) plan
Type 2 diabetes: Covered on formularies, usually with prior authorization.
Weight management: Rarely covered; depends on the insurer and state.
Heart and sleep apnea uses: Varies; check the formulary.
Medicare Part D or Medicare Advantage
Type 2 diabetes: Covered.
Weight management: Excluded by law, but a bridge program covers certain obesity GLP-1s for eligible enrollees from July 2026 to the end of 2027 for a flat monthly copay.
Heart and sleep apnea uses: Wegovy for heart risk and Zepbound for sleep apnea can be covered, with prior authorization.
Medicaid
Type 2 diabetes: Covered in every state.
Weight management: Optional for each state; KFF counted 13 states covering it in January 2026.
Heart and sleep apnea uses: Often reviewed case by case with prior authorization.
No insurance
Type 2 diabetes: Pay cash; compare pharmacy prices.
Weight management: Manufacturer self-pay programs, generic liraglutide, HSA or FSA funds.
Heart and sleep apnea uses: Same self-pay routes.

GLP-1 coverage by insurance type and use, October 2026
Insurance	Type 2 diabetes	Weight management	Heart and sleep apnea uses
Employer plan bought from an insurer	Usually covered, often with prior authorization or step therapy.	Only if the employer adds it; many do not.	Wegovy for heart risk and Zepbound for sleep apnea often covered with prior authorization.
Self-funded employer plan	Usually covered, with the plan’s own criteria.	The employer decides; state insurance rules do not apply.	Often covered with prior authorization.
Marketplace (ACA) plan	Covered on formularies, usually with prior authorization.	Rarely covered; depends on the insurer and state.	Varies; check the formulary.
Medicare Part D or Medicare Advantage	Covered.	Excluded by law, but a bridge program covers certain obesity GLP-1s for eligible enrollees from July 2026 to the end of 2027 for a flat monthly copay.	Wegovy for heart risk and Zepbound for sleep apnea can be covered, with prior authorization.
Medicaid	Covered in every state.	Optional for each state; KFF counted 13 states covering it in January 2026.	Often reviewed case by case with prior authorization.
No insurance	Pay cash; compare pharmacy prices.	Manufacturer self-pay programs, generic liraglutide, HSA or FSA funds.	Same self-pay routes.

Employer plans

Most people with work coverage get GLP-1s for diabetes, usually after prior authorization. Weight-management coverage is a choice the employer makes, often as an add-on, and some have dropped it because of cost; several state employee health plans, including North Carolina’s, have ended weight-loss coverage. Whether your plan is bought from an insurer or self-funded also matters: self-funded plans set their own rules, outside state insurance law. Your benefits team can tell you both what your plan covers and which kind it is.

Marketplace plans

Marketplace plans cover GLP-1s for diabetes, generally with prior authorization, but few cover them for weight management. Each insurer publishes its formulary, so check it before you enroll; open enrollment on HealthCare.gov runs from November 1 to January 15 in most states.

Medicare

Federal law bars Part D from covering drugs used only for weight loss. Plans do cover GLP-1s for type 2 diabetes, can cover Wegovy to lower cardiovascular risk in people with heart disease and Zepbound for obstructive sleep apnea, and from July 2026 to the end of 2027 the Medicare GLP-1 bridge program offers certain obesity GLP-1 medicines to eligible enrollees for a flat monthly copay. Compare plans in the Medicare Plan Finder during open enrollment, from October 15 to December 7. See our Medicare Part D guide.

Medicaid

Every state Medicaid program covers GLP-1s for type 2 diabetes. Covering them for weight management is optional, and states have moved in both directions as costs rose:

KFF counted 16 state Medicaid programs covering GLP-1s for obesity in October 2025 and 13 in January 2026.
California, New Hampshire, Pennsylvania and South Carolina ended adult coverage for obesity on January 1, 2026; California kept coverage for diabetes and reviews some other approved uses case by case.
North Carolina ended coverage in October 2025 and restored it in December 2025.
Michigan and Virginia narrowed coverage to people with the highest body mass index.

Because this keeps changing, check your state Medicaid program’s preferred drug list, or ask your plan, before relying on coverage.

If your plan does not cover it

A denial can often be appealed, and a covered use, such as heart risk or sleep apnea, may open coverage where weight management does not. Our guide to getting a GLP-1 covered walks through prior authorization, appeals and the self-pay routes, and our complete GLP-1 guide compares the medicines.

Frequently asked questions

Does Medicare cover Wegovy or Zepbound?

Not for weight loss alone, which federal law excludes. Part D can cover Wegovy to lower heart attack and stroke risk in people with heart disease and Zepbound for obstructive sleep apnea, and the Medicare GLP-1 bridge program covers certain obesity GLP-1s for eligible enrollees from July 2026 to the end of 2027.

Does Medicaid cover GLP-1s for weight loss?

In some states. KFF counted 13 state Medicaid programs covering GLP-1s for obesity in January 2026. California, New Hampshire, Pennsylvania and South Carolina ended coverage on January 1, 2026. Every state covers them for type 2 diabetes.

Will my employer plan cover Ozempic for weight loss?

Ozempic is approved for type 2 diabetes, so plans generally cover it for that use. For weight management, plans cover Wegovy or Zepbound only if your employer has chosen to include weight-loss drugs.

Does marketplace insurance cover GLP-1s?

For diabetes, yes, usually with prior authorization. For weight management, rarely. Check the formulary before you choose a plan during open enrollment.

What if my insurance does not cover it?

You can appeal a denial, use an approved use your plan covers, or pay through the manufacturers’ self-pay programs. Our coverage guide walks through each step.

Sources

GLP-1 coverage by insurance type: 2026 guide

Checked against federal rules and published state Medicaid changes: October 2026

Short answer

Coverage at a glance

Employer plan bought from an insurer

Type 2 diabetes: Usually covered, often with prior authorization or step therapy.

Weight management: Only if the employer adds it; many do not.

Heart and sleep apnea uses: Wegovy for heart risk and Zepbound for sleep apnea often covered with prior authorization.

Self-funded employer plan

Type 2 diabetes: Usually covered, with the plan’s own criteria.

Weight management: The employer decides; state insurance rules do not apply.

Heart and sleep apnea uses: Often covered with prior authorization.

Marketplace (ACA) plan

Type 2 diabetes: Covered on formularies, usually with prior authorization.

Weight management: Rarely covered; depends on the insurer and state.

Heart and sleep apnea uses: Varies; check the formulary.

Medicare Part D or Medicare Advantage

Type 2 diabetes: Covered.

Weight management: Excluded by law, but a bridge program covers certain obesity GLP-1s for eligible enrollees from July 2026 to the end of 2027 for a flat monthly copay.

Heart and sleep apnea uses: Wegovy for heart risk and Zepbound for sleep apnea can be covered, with prior authorization.

Medicaid

Type 2 diabetes: Covered in every state.

Weight management: Optional for each state; KFF counted 13 states covering it in January 2026.

Heart and sleep apnea uses: Often reviewed case by case with prior authorization.

No insurance

Type 2 diabetes: Pay cash; compare pharmacy prices.

Weight management: Manufacturer self-pay programs, generic liraglutide, HSA or FSA funds.

Heart and sleep apnea uses: Same self-pay routes.

GLP-1 coverage by insurance type and use, October 2026
Insurance	Type 2 diabetes	Weight management	Heart and sleep apnea uses
Employer plan bought from an insurer	Usually covered, often with prior authorization or step therapy.	Only if the employer adds it; many do not.	Wegovy for heart risk and Zepbound for sleep apnea often covered with prior authorization.
Self-funded employer plan	Usually covered, with the plan’s own criteria.	The employer decides; state insurance rules do not apply.	Often covered with prior authorization.
Marketplace (ACA) plan	Covered on formularies, usually with prior authorization.	Rarely covered; depends on the insurer and state.	Varies; check the formulary.
Medicare Part D or Medicare Advantage	Covered.	Excluded by law, but a bridge program covers certain obesity GLP-1s for eligible enrollees from July 2026 to the end of 2027 for a flat monthly copay.	Wegovy for heart risk and Zepbound for sleep apnea can be covered, with prior authorization.
Medicaid	Covered in every state.	Optional for each state; KFF counted 13 states covering it in January 2026.	Often reviewed case by case with prior authorization.
No insurance	Pay cash; compare pharmacy prices.	Manufacturer self-pay programs, generic liraglutide, HSA or FSA funds.	Same self-pay routes.

Employer plans

Medicare

Medicaid

Every state Medicaid program covers GLP-1s for type 2 diabetes. Covering them for weight management is optional, and states have moved in both directions as costs rose:

KFF counted 16 state Medicaid programs covering GLP-1s for obesity in October 2025 and 13 in January 2026.

California, New Hampshire, Pennsylvania and South Carolina ended adult coverage for obesity on January 1, 2026; California kept coverage for diabetes and reviews some other approved uses case by case.

North Carolina ended coverage in October 2025 and restored it in December 2025.

Michigan and Virginia narrowed coverage to people with the highest body mass index.

Because this keeps changing, check your state Medicaid program’s preferred drug list, or ask your plan, before relying on coverage.

Frequently asked questions

Does Medicare cover Wegovy or Zepbound?

Does Medicaid cover GLP-1s for weight loss?

Will my employer plan cover Ozempic for weight loss?

Ozempic is approved for type 2 diabetes, so plans generally cover it for that use. For weight management, plans cover Wegovy or Zepbound only if your employer has chosen to include weight-loss drugs.

Does marketplace insurance cover GLP-1s?

For diabetes, yes, usually with prior authorization. For weight management, rarely. Check the formulary before you choose a plan during open enrollment.

What if my insurance does not cover it?

You can appeal a denial, use an approved use your plan covers, or pay through the manufacturers’ self-pay programs. Our coverage guide walks through each step.